Iron Binding and Iron Removal Efficiency of Desferrioxamine Based Polymeric Iron Chelators: Influence of Molecular...

Area of Science:

• Biomaterials Science
• Medicinal Chemistry
• Nanotechnology

Background:

• Desferrioxamine (DFO) is an effective iron chelator but has limitations like short half-life and toxicity.
• Current DFO treatment requires frequent administration, impacting patient compliance and quality of life.
• Developing novel drug delivery systems can improve DFO's therapeutic profile.

Purpose of the Study:

• To investigate the influence of hyperbranched polyglycerol (HPG)-DFO conjugate properties on iron binding and removal.
• To evaluate the conjugates' efficacy in preventing iron-mediated protein oxidation.
• To explore the potential of HPG-DFO conjugates in combination therapy for iron overload.

Main Methods:

• Isothermal titration calorimetry (ITC) to assess iron binding thermodynamics.
• In vitro assays to determine iron removal efficiency from ferritin.
• Protein oxidation assays to evaluate protective effects against iron-mediated damage.

Main Results:

• HPG-DFO conjugate iron binding is influenced by conjugate size and DFO density.
• Lower molecular weight conjugates showed higher iron removal efficiency at room temperature.
• Higher molecular weight conjugates' efficacy increased at physiological temperatures.
• Iron removal from ferritin was significantly enhanced in the presence of a low molecular weight chelator.
• Conjugate molecular properties influenced the prevention of iron-mediated protein oxidation.

Conclusions:

• HPG-DFO conjugates offer tunable iron binding and enhanced iron removal capabilities.
• Conjugate molecular weight and DFO density are critical factors for optimizing performance.
• Combination therapy with HPG-DFO conjugates shows promise for improved iron overload treatment.
• These findings advance the understanding of polymeric chelator-iron interactions for therapeutic applications.